tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (HK:1093)
:1093
Hong Kong Market

CSPC Pharmaceutical Group (1093) Income Statement

Compare
15 Followers

CSPC Pharmaceutical Group Income Statement

Last quarter (Q4 2024), CSPC Pharmaceutical Group's total revenue was HK$14.59B, a decrease of -3.38% from the same quarter last year. In Q4, CSPC Pharmaceutical Group's net income was HK$1.59B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
HK$ 30.87BHK$ 34.60BHK$ 31.59BHK$ 33.59BHK$ 28.03B
Gross Profit
HK$ 21.60BHK$ 24.40BHK$ 22.73BHK$ 25.47BHK$ 21.00B
Operating Expenses
HK$ 15.89BHK$ 16.72BHK$ 15.80BHK$ 17.95BHK$ 14.89B
Depreciation and Amortization
HK$ 1.34BHK$ 1.12BHK$ 1.05BHK$ 1.04BHK$ 906.92M
EBITDA
HK$ 6.96BHK$ 8.53BHK$ 8.66BHK$ 9.28BHK$ 8.09B
Operating Income
HK$ 5.71BHK$ 7.68BHK$ 6.76BHK$ 6.25BHK$ 5.47B
Other Income/Expenses
HK$ 226.20MHK$ -290.75MHK$ 827.27MHK$ 597.84MHK$ 1.10B
Pretax Income
HK$ 5.94BHK$ 7.39BHK$ 7.58BHK$ 6.85BHK$ 7.17B
Net Income
HK$ 4.61BHK$ 5.87BHK$ 6.09BHK$ 5.61BHK$ 5.16B
Per Share Metrics
Basic EPS
HK$ 0.39HK$ 0.49HK$ 0.52HK$ 0.57HK$ 0.49
Diluted EPS
HK$ 0.39HK$ 0.49HK$ 0.52HK$ 0.57HK$ 0.49
Weighted Average Shares Outstanding
11.74B 11.87B 11.92B 11.95B 11.95B
Weighted Average Shares Outstanding (Diluted)
11.74B 11.87B 11.92B 11.95B 11.96B
Currency in HKD

CSPC Pharmaceutical Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis